Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Methadone deaths in pain and addiction populations.

Grant KJ, Baca CT.

J Gen Intern Med. 2010 Sep;25(9):898; author reply 899. doi: 10.1007/s11606-010-1411-0. No abstract available.

2.

Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes.

Reddy S, Fisch M, Bruera E.

J Pain Symptom Manage. 2004 Oct;28(4):301-3. No abstract available.

PMID:
15471646
3.

Methadone-related Torsades de Pointes in a sickle cell patient treated for chronic pain.

Porter BO, Coyne PJ, Smith WR.

Am J Hematol. 2005 Apr;78(4):316-7. No abstract available.

4.

[Torsades de pointes during methadone treatment].

Sánchez Hernández AM, Atienza Fernández F, Arenal Maíz A, González Torrecilla E, Puchol Calderón A, Almendral Garrote J.

Rev Esp Cardiol. 2005 Oct;58(10):1230-2. Spanish.

5.

Torsades de pointes with methadone.

[No authors listed]

Prescrire Int. 2005 Apr;14(76):61-2.

PMID:
15875343
6.

Possible association between methadone and potentially fatal cardiac arrhythmia.

[No authors listed]

J Pain Palliat Care Pharmacother. 2003;17(1):115-6. No abstract available.

PMID:
14640348
7.

Summaries for patients. Very high doses of methadone may cause abnormal heart rhythm.

[No authors listed]

Ann Intern Med. 2002 Sep 17;137(6):I42. No abstract available.

PMID:
12230382
8.

Methadone-associated QT prolongation and torsades de pointes.

George S.

Br J Hosp Med (Lond). 2007 Apr;68(4):221. No abstract available.

PMID:
17465110
9.

Torsade de pointes associated with very-high-dose methadone.

Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS.

Ann Intern Med. 2002 Sep 17;137(6):501-4.

PMID:
12230351
10.

Methadone-associated QT prolongation and torsades de pointes. Dubrey and Groscott-Mason's patient was underttreated for her atrial fibrillation.

Al-Sardar H.

Br J Hosp Med (Lond). 2007 Apr;68(4):221; author reply 221. No abstract available.

PMID:
17469230
11.

Torsade de pointes due to methadone.

Mokwe EO, Ositadinma O.

Ann Intern Med. 2003 Aug 19;139(4):W64. No abstract available.

PMID:
12966000
12.

Re: Methadone in the management of intractable neuropathic noncancer pain.

Fayez K, Juan-Diego H, Oscar A de LC.

Can J Neurol Sci. 2006 Feb;33(1):116. No abstract available.

PMID:
16583735
13.

Torsade de pointes due to methadone.

Sala M, Anguera I, Cervantes M.

Ann Intern Med. 2003 Aug 19;139(4):W64. No abstract available.

PMID:
12966001
14.

Methadone-induced torsade de pointes.

Nordt SP, Zilberstein J, Gold B.

Am J Emerg Med. 2011 May;29(4):476.e1-2. doi: 10.1016/j.ajem.2010.04.023. Epub 2010 Aug 1. No abstract available.

PMID:
20674223
15.

Methadone-induced torsades de pointes: a twist of fate.

Thanavaro KL, Thanavaro JL.

Heart Lung. 2011 Sep-Oct;40(5):448-53. doi: 10.1016/j.hrtlng.2010.12.008. Epub 2011 Mar 16.

PMID:
21411146
16.

QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone.

Gil M, Sala M, Anguera I, Chapinal O, Cervantes M, Guma JR, Segura F.

Am J Cardiol. 2003 Oct 15;92(8):995-7.

PMID:
14556883
17.

Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes.

Krantz MJ, Garcia JA, Mehler PS.

Pharmacotherapy. 2005 Apr;25(4):611-4.

PMID:
15977920
18.

Methadone and QT prolongation in HIV-infected patients.

Lucchini A, Barbaro G, Barbarini G.

Am J Cardiol. 2004 Jul 1;94(1):147-8. No abstract available.

PMID:
15219532
19.

Methadone deaths: risk factors in pain and addicted populations.

Modesto-Lowe V, Brooks D, Petry N.

J Gen Intern Med. 2010 Apr;25(4):305-9. doi: 10.1007/s11606-009-1225-0. Epub 2010 Jan 20. Review.

20.

Methadone-induced torsade de pointes in a patient with normal baseline QT interval.

Almehmi A, Malas AM, Yousufuddin M, Rosencrance JG.

W V Med J. 2004 Jul-Aug;100(4):147-8.

PMID:
15471174

Supplemental Content

Support Center